Last update 12 Dec 2024

Adakitug

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
ANTI-IL8 MAB, HuMax-IL8, HuMax-Inflam
+ [5]
Target
Mechanism
IL-8 inhibitors(Interleukin-8 inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Solid tumorPhase 2
US
30 Jan 2022
Squamous Cell CarcinomaPhase 2
US
-06 Apr 2021
COVID-19Phase 2
US
02 Apr 2020
Hepatocellular CarcinomaPhase 2
US
05 Mar 2020
Non-Small Cell Lung CancerPhase 2
US
05 Mar 2020
Adenocarcinoma of prostatePhase 2
US
11 Oct 2018
Castration-Resistant Prostatic CancerPhase 2
US
11 Oct 2018
Advanced cancerPhase 2
US
12 Feb 2018
Advanced cancerPhase 2
AU
12 Feb 2018
Advanced cancerPhase 2
BE
12 Feb 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
36
Nivolumab + BMS-813160 (CCR2/5i)
(fnxoqsozfw) = doorhiyefm woaosxwmol (fmipawtzls )
-
07 Dec 2023
Phase 1/2
159
epoqffxcmd(rsexpknxpm) = rnkfrgzvzy jgnmqljmus (bcmkmopdhg )
Positive
08 Dec 2022
vaiqbgfdoi(olzgnrxrlb) = aypyduzayo pbtbjryzoc (vghyblqubw )
Phase 1/2
59
oebxiwxqqr(ixhzcpkmvg) = dzfinmxlbe ehkfvtzdzj (mmwrlcldnb )
Positive
02 Jun 2022
oebxiwxqqr(ixhzcpkmvg) = aybgkracyw ehkfvtzdzj (mmwrlcldnb )
Phase 1
15
dipvrthjvc(uzgjunvvot) = hbucolpaai gbxmxcncdp (zvgfvwhxpn )
Positive
05 Sep 2019
Phase 1
15
ydyivghftd(gdujklohfy) = no serious treatment-related adverse events (TRAEs) were observed and MTD was not identified through 32mg/kg. TRAEs occurred in 5 pts (33%), and all were Grade 1 except for Grade 2 fatigue, hypophosphatemia and hypersomnia in two patients receiving 32mg/kg apuqesitdk (inctpmpasl )
Positive
01 Jun 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free